The global position, navigation, and timing (PNT) solution market has experienced remarkable growth in recent years due to technological advancements and increasing demand for precise, efficient, cost-effective military capabilities. The global positioning, navigation, and timing (PNT) solution market refers to the industry providing satellite-based positioning, navigation, and timing services to various sectors such as aviation, maritime, land transportation, and defense.

These services are used for navigation, surveying, mapping, timing, and synchronization applications. The market is driven by the rising adoption of GPS-enabled devices and the growing demand for location-based services. Additionally, the emergence of new applications, such as autonomous vehicles and smart cities, is expected to fuel the demand for PNT solutions further.

The PNT solution market is characterized by intense competition, with several key players operating in the industry. Notable companies include Garmin Ltd., Trimble Inc., BAE Systems, Inc., NovAtel Inc., Qualcomm Technologies, Inc., and others. These companies heavily invest in research and development to introduce innovative products.

The market also features smaller and medium-sized companies offering specialized products and services. With the increasing demand for PNT solutions, the market is anticipated to experience significant growth in the coming years as more industries recognize the benefits of utilizing these services.

The market can be segmented based on application, end users, component, GNSS correction services by type and GNSS correction services by end users, and it is expected to witness continued growth as key players and defense forces invest in advanced technologies to enhance performance and effectiveness, leading to new opportunities for growth and innovation in the sector.

Market Introduction

The global position, navigation, and timing (PNT) solution market has witnessed significant growth and advancements in recent years. The widespread use of smartphones, wearable devices, and vehicle navigation systems has fueled the need for accurate positioning and navigation capabilities. PNT solutions can be integrated with other technologies to offer comprehensive solutions. For instance, the integration of PNT with artificial intelligence (AI) and machine learning (ML) enables intelligent navigation and real-time decision-making. Similarly, the fusion of PNT with sensor technologies such as LiDAR and radar enhances mapping and surveying capabilities.

Furthermore, in the field of PNT solutions, the key players are continuously working on the development of advanced algorithms, use of multi-constellation satellite systems, integration of additional sensors, and leveraging technologies such as differential GPS (DGPS) and real-time kinematic (RTK) positioning to enhance the accuracy and precision of PNT solutions.

Industrial Impact

The global position, navigation, and timing (PNT) solution market is witnessing rapid growth due to the growing demand for GPS-enabled devices and the rising popularity of location-based services. Additionally, the emergence of advanced technologies such as autonomous vehicles, unmanned aerial vehicles (UAVs), and smart cities has further propelled the demand for PNT solutions.

These solutions enable location-based services, efficient transportation systems, asset tracking, and synchronization of critical infrastructure. However, with the increased reliance on PNT solutions, cybersecurity has become a significant concern. Protecting PNT systems from spoofing, jamming, and other cyber threats is crucial. Market players are investing in developing secure PNT solutions and implementing encryption and authentication mechanisms.

Market Segmentation:

Segmentation 1: by Application
•    Navigation
•    Positioning
•    Precision Timing
•    Geo-Location

The global position, navigation, and timing (PNT) solution market is expected to generate huge revenues from the navigation application segment, followed by positioning. Navigation solutions are poised to lead the market due to the growing use of autonomous systems, such as drones and self-driving cars. They utilize satellite-based positioning technologies such as global navigation satellite systems (GNSS) to determine accurate coordinates and enable navigation in various environments. Additionally, navigation applications include personal navigation devices, vehicle navigation systems, marine navigation systems, and aviation navigation systems. Hence, to meet the demand for these systems, new navigation technologies are being developed.

Segmentation 2: by End User
•    Defense
•    Commercial
•    Government and Civil

The global position, navigation, and timing (PNT) solution (satellite) market is expected to be dominated by the defense in 2023, with a 40.8% share in terms of revenue due to the high demand for PNT solutions in modern military operations.

Additionally, precision-guided systems, such as guided missiles, smart bombs, and artillery systems, require highly accurate PNT data for targeting and hitting specific objectives with precision. The defense sector is investing in advanced PNT solutions to enhance the effectiveness and accuracy of such systems, resulting in increased demand.

Segmentation 3: by Component
•    Satellite
•    Ground

The global position, navigation, and timing (PNT) solution market by component includes ground, which is expected to dominate the market.

Segmentation 4: GNSS Correction Services by Type
•    Precise Point Positioning (PPP)
•    Real-time Kinematic (RTK)
•    PPP-RTK
•    WARTK

The global position, navigation, and timing (PNT) solution market for GNSS correction services by type includes precise point positioning (PPP), which is expected to dominate the market.

Segmentation 5: GNSS Correction Services by End User
•    Defense
•    Commercial
•    Government and Civil

Segmentation 6: by Region (Satellite)
•    North America – U.S. and Canada
•    Europe – U.K., France, Germany, Russia, and Rest-of-Europe
•    Asia-Pacific – China, India, Japan, and Rest-of-Asia-Pacific
•    Rest-of-the-World – South America and Middle East, and Africa

North America is anticipated to grow at a CAGR of 11.07%. The presence of a larger number of established position, navigation, and timing (PNT) solution providers is driving the market in the region. The presence of major industry players such as Northrop Grumman, Raytheon Technologies Corporation, NovAtel, and Qualcomm Technologies, Inc. within the region with growth strategies such as partnerships are paving the way for market opportunities. Additionally, the emergence of advanced technologies, such as artificial intelligence (AI), machine learning (ML), and Internet of Things (IoT) devices, has fueled the demand for accurate and reliable PNT solutions in the region.

The U.S. dominates the global position, navigation, and timing (PNT) solution market in the region, with various key players producing PNT solutions for various applications such as navigation, positioning, precision timing, geo-location, and GNSS correction. In addition, the U.S. has expertise in various fields, including satellite navigation, geospatial technologies, and wireless communications. This technological advancement provides a solid foundation for developing and implementing advanced PNT solutions.

Recent Developments in the Global Position, Navigation, and Timing (PNT) Solution Market

• In April 2023, Orolia, a subsidiary of Safran, partnered with Xona Space Systems to integrate Xona’s LEO constellation and navigation signals into its Skydel-powered simulation and testing solutions. Xona Space Systems is developing PULSAR, a PNT service that utilizes a commercial constellation of LEO satellites for high-performance positioning, navigation, and timing.
•  In April 2023, Qualcomm Technologies, Inc. partnered with Xiaomi to verify meter-level positioning in the Xiaomi 12T Pro smartphone powered by Snapdragon 8+ Gen 1 in Germany. This technology enhances the accuracy of location-based applications such as ridesharing, fitness, and in-vehicle navigation. It is enabled through Qualcomm Technologies, Inc.’s Meter-Level Positioning for Mobile and Trimble RTX correction services.
• In March 2023, NextNav Inc. partnered with Prepared, an emergency multimedia services provider, to provide its precise location solution. NextNav Inc.’s Pinnacle would power Prepared’s z-axis location ecosystem and provide callers and responders with the most accurate data and visualization tools.

Demand – Drivers and Limitations

Market Demand Drivers: Growth of the Autonomous Vehicles Market

The growth of the autonomous vehicles market has driven the demand for PNT solutions. PNT technologies enable autonomous vehicles to navigate accurately, plan optimal routes, avoid collisions, and operate safely. Key market players are actively working on improving the accuracy, robustness, and resilience of PNT technologies to meet the specific requirements of autonomous vehicles.

Market Challenges: GPS Jamming and Spoofing Attacks

Spoofing and jamming are two methods employed by adversaries to interfere with position, navigation, and time solutions obtained from GPS/GNSS. Spoofing involves manipulating a GPS receiver to generate inaccurate position calculations, while jamming occurs when local RF signals overpower GPS signals, rendering the GPS receiver unable to function properly.

Market Opportunities: Emergence of Terrestrial-Based PNT Solutions

Terrestrial-based PNT systems are crucial in enhancing the positioning and navigation solutions of various vehicles, including unmanned aerial, ground, and maritime vehicles. They also contribute to the security of critical infrastructure, working in conjunction with GNSS technologies. In addition, the advent of sensor-based technologies has led to the development of various methods for terrestrial-based location determination and navigation. These methods rely on a range of sensor systems, including radio-frequency identification (RFID), wireless sensor networks, cellular networks, wireless local area networks (LANs), and numerous other sensor-based technologies.

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of solutions available for deployment and their potential globally. Moreover, the study provides the reader with a detailed understanding of the global position, navigation, and timing (PNT) solution by component (hardware and software).

Growth/Marketing Strategy: The global position, navigation, and timing (PNT) solution market has seen major development by key players operating in the market, such as contract, collaboration, and joint venture. The favored strategy for the companies has been contracts to strengthen their position in the global position, navigation, and timing (PNT) solution market. For instance, in April 2023, Thales Alenia Space signed a contract with KT SAT Corporation Ltd. (KT SAT) and announced that KOREASAT 6A would include a satellite-based augmentation system (SBAS) payload. The SBAS payload would enhance the continuity and availability of the Korea Augmentation Satellite System (KASS).

Competitive Strategy: Key players in the global position, navigation, and timing (PNT) solution market analyzed and profiled in the study involve major global position, navigation, and timing (PNT) solution companies providing solutions, respectively. Moreover, a detailed market share analysis of the players operating in the global position, navigation, and timing (PNT) solution market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Methodology: The research methodology design adopted for this specific study includes a mix of data collected from primary and secondary data sources. Both primary resources (key players, market leaders, and in-house experts) and secondary research (a host of paid and unpaid databases), along with analytical tools, are employed to build the predictive and forecast models.

Data and validation have been taken into consideration from both primary sources as well as secondary sources.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights, which are gathered from primary experts.

The top established position, navigation, and timing (PNT) solution providers hold around 79% of the presence in the market. The start-ups in the market hold around 21% of the global position, navigation, and timing (PNT) solution market.

Key Companies Profiled:

•    NextNav Inc.
•    BAE Systems, Inc.
•    Qualcomm Technologies, Inc.
•    NovAtel (Hexagon AB)
•    Raytheon Technologies Corporation
•    Safran
•    Booz Allen Hamilton Inc.
•    Garmin Ltd.
•    Northrop Grumman Corporation
•    Saab Ab
•    Telespazio S.p.A.
•    Thales Group
•    Amazon Web Services, Inc.
•    L3Harris Technologies, Inc.

The post Position, Navigation, and Timing (PNT) Solution Market – A Global and Regional Analysis: Focus on Application, End User, Component, and Services – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witnessing a CAGR of 17.56% during the forecast period 2022-2027. The market is driven by factors such as the increasing adoption of NGS in various research and diagnostics fields, growing prevalence of non-communicable disorders, and advancement in the performance of NGS platforms.

Market Lifecycle Stage

The Asia-Pacific and Middle East NGS market is highly consolidated. This market still holds significant potential for growth as technological developments in NGS platforms and initiatives to integrate genomics in healthcare are ongoing.

The opportunity for growth of the Asia-Pacific and Middle East NGS market lies in development of economical and portable technologies.

Impact of COVID-19

Next-generation sequencing (NGS)-based products are widely employed in research and diagnosis of diseases such as cancer, as well as providing cancer patients with appropriate and individualized therapy. Because the market is dominated primarily by manufacturers of next-generation sequencing instruments, kits, and assays, as well as service providers that provide gene panels and testing services using next-generation sequencing for oncology, the pandemic had a negative impact on the market’s revenue growth.

However, during the COVID-19 pandemic, next-generation sequencing (NGS) and analytics were increasingly employed for sequencing the SARS-CoV-2 virus, to track its mutations, and manage population health. For example, in October 2022, Kyrgyzstan began building next-generation sequencing capabilities for SARS-CoV-2. Leaders in this sequencing industry have predicted a greater push toward local manufacturing rather than its dependency on import activities. The pandemic revealed cracks in the supply chain, prompting Asia-Pacific and Middle East countries to strengthen local production of medicines where possible.

Market Segmentation:

Segmentation 1: by Offerings
• Consumables
• Equipment
• Services

The Asia-Pacific and Middle East NGS market (by offerings) is expected to be dominated by the consumables segment.

Segmentation 2: by Platform
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Pacific BioSciences of California, Inc.
• Oxford Nanopore Technologies plc.
• Other Companies

The Asia-Pacific and Middle East NGS market (by platform) is expected to be dominated by Illumina, Inc.

Segmentation 3: by Throughput
• High-Throughput
• Medium-Throughput
• Low-Throughput

The Asia-Pacific and Middle East NGS market (by throughput) is expected to be dominated by the high-throughput segment.

Segmentation 4: by Technology Type
• Sequencing by Synthesis
• Ion Torrent Semiconductor Sequencing
• Single Molecule Real-Time Sequencing
• Nanopore Sequencing Technology
• Other Technologies

The Asia-Pacific NGS market (by technology type) is expected to be dominated by the sequencing by synthesis segment.

Segmentation 5: by Application
• Clinical Diagnostics
• Translational Research
• Other Applications

The Asia-Pacific NGS market (by technology type) is expected to be dominated by the translational research segment.

Segmentation 6: by End User
• Academic and Research Institutes
• Clinical Laboratories
• Pharmaceutical and Biotechnology Companies
• Other End Users

The Asia-Pacific NGS market (by end user) is expected to be dominated by the academic and research insitutes segment.

Segmentation 7: by Country
• Asia-Pacific
o Japan
o India
o South Korea
o Australia
o Singapore
o New Zealand
o Rest-of-Asia-Pacific
• Middle East
o U.A.E.
o K.S.A.
o Egypt
o Israel
o Rest-of-Middle East

The Asia-Pacific NGS market (by country) is expected to be dominated by Japan and the Middle East NGS market (by country) is expected to be dominated by the U.A.E.

*Note: Each country is further segmented by offering, equipment (units), platform.

Recent Developments in the Asia-Pacific and Middle East NGS Market

• In October 2022, the company introduced Revio and Onso – new sequencing systems; Revio is a long-read sequencing system that allows the sequencing of up to 1,300 human whole genomes per year, while Onso is a benchtop short-read DNA sequencing platform. The system enables scaling of the use of PacBio’s HiFi sequencing technology for large studies in human genetics, cancer research, and agricultural genomics, among others.
• In September 2022, Illumina, Inc. introduced Illumina Complete Long-Reads (INFINITY) for human whole-genome sequencing (WGS). This resulted in a high-performance, streamlined, integrated method. Furthermore, the platform showed compatible with all NovaSeq systems for the synthesis of thousands of long-read genomes every year.
• In September 2022, Illumina, Inc. introduced the first FDA-registered and CE-marked in vitro diagnostic (IVD) high-throughput sequencer, the NovaSeq 6000 Dx. The NovaSeq 6000 Dx is a versatile platform that provides the greatest levels of compliance while also delivering useful insights for patient care.
• In August 2022, Illumina, Inc. teamed with Minderoo Foundation and contributed $27.8 million to improve genetic knowledge of marine systems. This innovative collaboration used Illumina’s NextSeq 2000 sequencing system to assess and understand marine life in seas.
• In April 2022, the company expanded its relationship with Genomics England, which is evaluating the therapeutic and scientific uses of full genomic analysis of cancer tumors using nanopore technology in an ongoing project.
• In March 2022, the company introduced CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer. This sequencer is fully automated, producing data in a single day.
• In January 2022, Pacific Biosciences of California, Inc. collaborated with Genomics England, a company created to deliver the 100,000 Genomes Project to study PacBio’s technology for the identification of genetic variants in cancer and rare disease cases. As part of the collaboration, Genomics England will re-sequence biobank samples collected during the 100,000 Genomes Project using Pacific Biosciences of California, Inc.’s long-read sequencing technology to identify additional genomic variants that are not readily accessible by short-read sequencing technologies.

Demand – Drivers and Limitations

The following are the drivers for the Asia-Pacific and Middle East NGS market:

• Increasing Adoption of NGS in Various Research and Diagnostics Fields
• Growing Prevalence of Non-Communicable Diseases
• Advancement in the Performance of NGS Platforms

The market is expected to face some limitations as well due to the following challenges:

• Dearth of Skilled Professionals in Middle East Countries
• High Cost of Installation and Maintenance of the Equipment
• Reimbursement and Regulatory Policies of NGS

How can this report add value to an organization?

Type: The Asia-Pacific and Middle East NGS market has been extensively segmented on the basis of various categories such as offerings, throughput, and platform, among others. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Synergistic activities and product launches/approvals accounted for the maximum number of key developments, i.e., over 70% of the total developments in the global Asia-Pacific and Middle East NGS market.

Competitive Strategy: The Asia-Pacific and Middle East NGS market is highly consolidated, with around six key players accounting for a vast majority of the market share. Key players in the Asia-Pacific and Middle East NGS market analyzed and profiled in the study involve established and players that offer various kinds of NGS platforms, consumables, and services.

Key Market Players and Competition Synopsis

The Asia-Pacific an Middle East NGS market is highly consolidated, with around six key players accounting for a vast majority of the market share.

Key Companies Profiled

• BGI Group
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Pacific Biosciences of California, Inc.
• Oxford Nanopore Technologies plc.

Table of Contents

1 Markets
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.2 Industry Outlook
1.2.1 NGS: Overview
1.2.2 Asia-Pacific and Middle East NGS Market: Overview
1.2.3 Emerging Applications of NGS in the Asia-Pacific and Middle East NGS Market
1.2.4 COVID-19 Impact on Asia-Pacific and Middle East NGS Market
1.2.5 Supply Chain Analysis
1.2.5.1 Key Entities in Supply Chain
1.3 Industry Analysis
1.3.1 Legal Requirements and Framework in Asia-Pacific
1.3.2 Legal Requirements and Framework in the Middle East
1.3.3 Genome Projects in Asia-Pacific and the Middle East
1.4 Market Dynamics
1.4.1 Impact Analysis
1.4.2 Market Drivers
1.4.2.1 Increasing Adoption of NGS in Various Research and Diagnostics Fields
1.4.2.2 Growing Prevalence of Non-Communicable Diseases
1.4.2.3 Advancement in the Performance of NGS Platforms
1.4.3 Market Restraints
1.4.3.1 Dearth of Skilled Professionals in Middle East Countries
1.4.3.2 High Cost of Installation and Maintenance of the Equipment
1.4.3.3 Reimbursement and Regulatory Policies of NGS
1.4.4 Market Opportunities
1.4.4.1 Development of Economical and Portable Technologies
2 Asia-Pacific and Middle East NGS Market (by Offering)
2.1 Overview
2.2 Consumables
2.2.1 Asia-Pacific
2.2.2 Middle East
2.3 Equipment
2.3.1 Asia-Pacific
2.3.2 Middle East
2.4 Services
2.4.1 Asia-Pacific
2.4.2 Middle East
3 Asia-Pacific and Middle East NGS Market (by Platform)
3.1 Overview
3.1.1 Asia-Pacific
3.1.2 Middle East
3.2 Illumina, Inc.
3.2.1 iSeq
3.2.1.1 Asia-Pacific
3.2.1.2 Middle East
3.2.2 MiniSeq
3.2.2.1 Asia-Pacific
3.2.2.2 Middle East
3.2.3 MiSeq
3.2.3.1 Asia-Pacific
3.2.3.2 Middle East
3.2.4 NextSeq
3.2.4.1 Asia-Pacific
3.2.4.2 Middle East
3.2.5 NovaSeq
3.2.5.1 Asia-Pacific
3.2.5.2 Middle East
3.3 Thermo Fisher Scientific Inc.
3.3.1 Ion PGM
3.3.1.1 Asia-Pacific
3.3.1.2 Middle East
3.3.2 Ion GeneStudio S5
3.3.2.1 Asia-Pacific
3.3.2.2 Middle East
3.3.3 Ion Proton
3.3.3.1 Asia-Pacific
3.3.3.2 Middle East
3.3.4 Ion Torrent Genexus
3.3.4.1 Asia-Pacific
3.3.4.2 Middle East
3.4 Pacific Biosciences of California, Inc.
3.4.1 Sequel II/IIe
3.4.1.1 Asia-Pacific
3.4.1.2 Middle East
3.5 Oxford Nanopore Technologies plc.
3.5.1 MinION
3.5.1.1 Asia-Pacific
3.5.1.2 Middle East
3.5.2 GridION
3.5.2.1 Asia-Pacific
3.5.2.2 Middle East
3.5.3 PromethION
3.5.3.1 Asia-Pacific
3.5.3.2 Middle East
3.6 Other Companies
3.6.1 Asia-Pacific
3.6.2 Middle East
4 Asia-Pacific and Middle East NGS Market (by Throughput)
4.1 Overview
4.1.1 Asia-Pacific
4.1.2 Middle East
4.2 High-Throughput
4.2.1 Asia-Pacific
4.2.2 Middle East
4.3 Medium-Throughput
4.3.1 Asia-Pacific
4.3.2 Middle East
4.4 Low-Throughput
4.4.1 Asia-Pacific
4.4.2 Middle East
5 Asia-Pacific NGS Market (by Technology Type)
5.1 Overview
5.2 Sequencing by Synthesis
5.3 Ion Torrent Semiconductor Sequencing
5.4 Single Molecule Real-Time Sequencing
5.5 Nanopore Sequencing Technology
5.6 Other Technologies
6 Asia-Pacific NGS Market (by Application)
6.1 Overview
6.2 Clinical Diagnostics
6.2.1 Oncology
6.2.2 Infectious Diseases
6.2.3 Reproductive Genetics
6.2.4 Other Diagnostics Applications
6.3 Translational Research
6.3.1 Clinical Research
6.3.2 Agricultural Research
6.3.3 Other Translational Research
6.4 Other Applications
7 Asia-Pacific NGS Market (by End User)
7.1 Overview
7.2 Academic and Research Institutes
7.3 Clinical Laboratories
7.4 Pharmaceutical and Biotechnology Companies
7.5 Other End Users
8 Asia-Pacific NGS Market (by Country)
8.1 Overview
8.2 Key Distributors
8.3 Japan
8.4 India
8.5 South Korea
8.6 Australia
8.7 Singapore
8.8 New Zealand
8.9 Rest-of-Asia-Pacific
9 Middle East NGS Market (by Country)
9.1 Overview
9.2 Key Distributors
9.3 U.A.E.
9.4 K.S.A.
9.5 Egypt
9.6 Israel
9.7 Rest-of-Middle East
10 Markets – Competitive Benchmarking & Company Profiles
10.1 Competitive Landscape
10.1.1 Overview
10.1.2 Corporate Strategies
10.1.2.1 Mergers and Acquisitions
10.1.2.2 Synergistic Activities
10.1.2.3 Business Expansions and Funding
10.1.3 Business Strategies
10.1.3.1 Product Launches/Upgradations/Approvals
10.2 Market Share Analysis
10.3 Growth-Share Analysis for Asia-Pacific NGS Market (by End User)
10.4 Growth-Share Analysis for Middle East NGS Market (by Throughput)
10.5 Company Profiles
10.5.1 BGI Group
10.5.1.1 Company Overview
10.5.1.2 Role of BGI Group in the Asia-Pacific and Middle East NGS Market
10.5.1.3 Overall Product Portfolio
10.5.1.4 Key Developments
10.5.1.5 Analyst Perception
10.5.2 Illumina, Inc.
10.5.2.1 Company Overview
10.5.2.2 Role of Illumina, Inc. in the Asia-Pacific and Middle East NGS Market
10.5.2.3 Overall Product Portfolio
10.5.2.4 Recent Developments
10.5.2.5 Financials
10.5.2.6 Analyst Perception
10.5.3 Thermo Fisher Scientific Inc.
10.5.3.1 Company Overview
10.5.3.2 Role of Thermo Fisher Scientific Inc. in the Asia-Pacific and Middle East NGS Market
10.5.3.3 Overall Product Portfolio
10.5.3.4 Recent Developments
10.5.3.5 Financials
10.5.3.6 Analyst Perception
10.5.4 Pacific Biosciences of California, Inc.
10.5.4.1 Company Overview
10.5.4.2 Role of Pacific Biosciences of California, Inc. in the Asia-Pacific and Middle East NGS Market
10.5.4.3 Overall Product Portfolio
10.5.4.4 Recent Developments
10.5.4.5 Financials
10.5.4.6 Analyst Perception
10.5.5 Oxford Nanopore Technologies plc.
10.5.5.1 Company Overview
10.5.5.2 Role of Oxford Nanopore Technologies plc. in the Asia-Pacific and Middle East NGS Market
10.5.5.3 Overall Product Portfolio
10.5.5.4 Recent Developments
10.5.5.5 Financials
10.5.5.6 Analyst Perception

List of Figures

Figure 1: Asia-Pacific and Middle East NGS Market, Impact Analysis
Figure 2: Growth-Share Analysis for Middle East NGS Market (by Key Players), 2021
Figure 3: Asia-Pacific and Middle East NGS Market (by Region), Share (%), 2021 and 2027
Figure 4: Asia-Pacific and Middle East NGS Market Segmentation
Figure 5: Asia-Pacific and Middle East NGS Market Research Methodology
Figure 6: Primary Research Methodology
Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
Figure 8: Top-Down Approach (Segment-Wise Analysis)
Figure 9: Asia-Pacific and Middle East NGS Market, NGS Workflow
Figure 10: Asia-Pacific NGS Market, $Million, 2021-2027
Figure 11: Middle East NGS Market, $Million, 2021-2027
Figure 12: Asia-Pacific and Middle East NGS Market, NGS Applications
Figure 13: Asia-Pacific and Middle East NGS Market, Supply Chain Analysis
Figure 14: Asia-Pacific and Middle East NGS Market, Impact Analysis
Figure 15: Asia-Pacific and Middle East NGS Market, Applications of NGS in Various Research and Diagnostics Fields
Figure 16: Asia-Pacific and Middle East NGS Market, Comparison of NGS Technologies
Figure 17: Asia-Pacific and Middle East NGS Market, Major Factors Influencing Adoption of NGS in Various Research and Diagnostics Fields
Figure 18: Asia-Pacific and Middle East NGS Market, Non-Communicable Diseases (NCDs) Mortality Rate (by Country), 2020 and 2022
Figure 19: Asia-Pacific and Middle East NGS Market, Different Generations of Sequencing
Figure 20: Asia-Pacific and Middle East NGS Market, Percentage of People with Shortage of Skills in the Middle East
Figure 21: Asia-Pacific NGS Market (by Offering), Share (%), 2021 and 2027
Figure 22: Middle East NGS Market (by Offering), Share (%), 2021 and 2027
Figure 23: Asia-Pacific NGS Market (Consumables), $Million, 2021-2027
Figure 24: Middle East NGS Market (Consumables), $Million, 2021-2027
Figure 25: Asia-Pacific NGS Market (Equipment), $Million, 2021-2027
Figure 26: Middle East NGS Market (Equipment), $Million, 2021-2027
Figure 27: Asia-Pacific NGS Market (Services), $Million, 2021-2027
Figure 28: Middle East NGS Market (Services), $Million, 2021-2027
Figure 29: Asia-Pacific NGS Market (by Platform), Share (%), 2021 and 2027
Figure 30: Asia-Pacific NGS Market (by Platform), Units, 2021 and 2027
Figure 31: Middle East NGS Market (by Platform), Share (%), 2021 and 2027
Figure 32: Middle East NGS Market (by Platform), Units, Share (%), 2021 and 2027
Figure 33: Asia-Pacific NGS Market (Illumina, Inc.), $Million, 2021-2027
Figure 34: Asia-Pacific NGS Market (Illumina, Inc.), Units, 2021-2027
Figure 35: Illumina, Inc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 36: Middle East NGS Market (Illumina, Inc.), $Million, 2021-2027
Figure 37: Middle East NGS Market (Illumina, Inc.), Units, 2021-2027
Figure 38: Illumina, Inc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 39: Asia-Pacific NGS Market (iSeq), $Million, 021-2027
Figure 40: Asia-Pacific NGS Market (iSeq), Units, 2021-2027
Figure 41: Middle East NGS Market (iSeq), $Million, 2021-2027
Figure 42: Middle East NGS Market (iSeq), Units, 2021-2027
Figure 43: Asia-Pacific NGS Market (MiniSeq), $Million, 2021-2027
Figure 44: Asia-Pacific NGS Market (MiniSeq), Units, 2021-2027
Figure 45: Middle East NGS Market (MiniSeq), $Million, 2021-2027
Figure 46: Middle East NGS Market (MiniSeq), Units, 2021-2027
Figure 47: Asia-Pacific NGS Market (MiSeq), $Million, 2021-2027
Figure 48: Asia-Pacific NGS Market (MiSeq), Units, 2021-2027
Figure 49: Middle East NGS Market (MiSeq), $Million, 2021-2027
Figure 50: Middle East NGS Market (MiSeq), Units, 2021-2027
Figure 51: Asia-Pacific NGS Market (NextSeq), $Million, 2021-2027
Figure 52: Asia-Pacific NGS Market (NextSeq), Units, 2021-2027
Figure 53: Middle East NGS Market (NextSeq), $Million, 2021-2027
Figure 54: Middle East NGS Market (NextSeq), Units, 2021-2027
Figure 55: Asia-Pacific NGS Market (NovaSeq), $Million, 2021-2027
Figure 56: Asia-Pacific NGS Market (NovaSeq), Units, 2021-2027
Figure 57: Middle East NGS Market (NovaSeq), $Million, 2021-2027
Figure 58: Middle East NGS Market (NovaSeq), Units, 2021-2027
Figure 59: Asia-Pacific NGS Market (Thermo Fisher Scientific Inc.), $Million, 2021-2027
Figure 60: Asia-Pacific NGS Market (Thermo Fisher Scientific Inc.), Units, 2021-2027
Figure 61: Thermo Fisher Scientific Inc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 62: Middle East NGS Market (Thermo Fisher Scientific Inc.), $Million, 2021-2027
Figure 63: Middle East NGS Market (Thermo Fisher Scientific Inc.), Units, 2021-2027
Figure 64: Thermo Fisher Scientific Inc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 65: Asia-Pacific NGS Market (Ion PGM), $Million, 2021-2027
Figure 66: Asia-Pacific NGS Market (Ion PGM), Units, 2021-2027
Figure 67: Middle East NGS Market (Ion PGM), $Million, 2021-2027
Figure 68: Middle East NGS Market (Ion PGM), Units, 2021-2027
Figure 69: Asia-Pacific NGS Market (Ion GeneStudio S5), $Million, 2021-2027
Figure 70: Asia-Pacific NGS Market (Ion GeneStudio S5), Units, 2021-2027
Figure 71: Middle East NGS Market (Ion GeneStudio S5), $Million, 2021-2027
Figure 72: Middle East NGS Market (Ion GeneStudio S5), Units, 2021-2027
Figure 73: Asia-Pacific NGS Market (Ion Proton), $Million, 2021-2027
Figure 74: Asia-Pacific NGS Market (Ion Proton), Units, 2021-2027
Figure 75: Middle East NGS Market (Ion Proton), $Million, 2021-2027
Figure 76: Middle East NGS Market (Ion Proton), Units, 2021-2027
Figure 77: Asia-Pacific NGS Market (Ion Torrent Genexus), $Million, 2021-2027
Figure 78: Asia-Pacific NGS Market (Ion Torrent Genexus), Units, 2021-2027
Figure 79: Middle East NGS Market (Ion Torrent Genexus), $Million, 2021-2027
Figure 80: Middle East NGS Market (Ion Torrent Genexus), Units, 2021-2027
Figure 81: Asia-Pacific NGS Market (Pacific Biosciences of California, Inc.), $Million, 2021-2027
Figure 82: Asia-Pacific NGS Market (Pacific Biosciences of California, Inc.), Units, 2021-2027
Figure 83: Pacific Biosciences of California, Inc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 84: Middle East NGS Market (Pacific Biosciences of California, Inc.), $Million, 2021-2027
Figure 85: Middle East NGS Market (Pacific Biosciences of California, Inc.), Units, 2021-2027
Figure 86: Asia-Pacific NGS Market (Sequel II/IIe), $Million, 2021-2027
Figure 87: Asia-Pacific NGS Market (Sequel II/IIe), Units, 2021-2027
Figure 88: Middle East NGS Market (Sequel II/IIe), $Million, 2021-2027
Figure 89: Middle East NGS Market (Sequel II/IIe), Units, 2021-2027
Figure 90: Asia-Pacific NGS Market (Oxford Nanopore Technologies plc.), $Million, 2021-2027
Figure 91: Asia-Pacific NGS Market (Oxford Nanopore Technologies plc.), Units, 2021-2027
Figure 92: Oxford Nanopore Technologies plc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 93: Middle East NGS Market (Oxford Nanopore Technologies plc.), $Million, 2021-2027
Figure 94: Middle East NGS Market (Oxford Nanopore Technologies plc.), Units, 2021-2027
Figure 95: Oxford Nanopore Technologies plc. (by Equipment), Units, Share (%), 2021 and 2027
Figure 96: Asia-Pacific NGS Market (MinION), $Million, 2021-2027
Figure 97: Asia-Pacific NGS Market (MinION), Units, 2021-2027
Figure 98: Middle East NGS Market (MinION), $Million, 2021-2027
Figure 99: Middle East NGS Market (MinION), Units, 2021-2027
Figure 100: Asia-Pacific NGS Market (GridION), $Million, 2021-2027
Figure 101: Asia-Pacific NGS Market (GridION), Units, 2021-2027
Figure 102: Middle East NGS Market (GridION), $Million, 2021-2027
Figure 103: Middle East NGS Market (GridION), Units, 2021-2027
Figure 104: Asia-Pacific NGS Market (PromethION), $Million, 2021-2027
Figure 105: Asia-Pacific NGS Market (PromethION), Units, 2021-2027
Figure 106: Middle East NGS Market (PromethION), $Million, 2021-2027
Figure 107: Middle East NGS Market (PromethION), Units, 2021-2027
Figure 108: Asia-Pacific NGS Market (Other Companies), Units, 2021-2027
Figure 109: Middle East NGS Market (Other Companies), $Million, 2021-2027
Figure 110: Middle East NGS Market (Other Companies), Units, 2021-2027
Figure 111: Asia-Pacific and Middle East NGS Market (by Throughput)
Figure 112: Asia-Pacific NGS Market (by Throughput), Share (%), 2021 and 2027
Figure 113: Middle East NGS Market (by Throughput), Share (%), 2021 and 2027
Figure 114: Asia-Pacific NGS Market (High-Throughput), $Million, 2021-2027
Figure 115: Asia-Pacific NGS Market (High-Throughput, by Equipment), Units, 2021-2027
Figure 116: Asia-Pacific NGS Market (High-Throughput, by Offering), $Million, 2021-2027
Figure 117: Middle East NGS Market (High-Throughput), $Million, 2021-2027
Figure 118: Middle East NGS Market (High-Throughput, by Equipment), Units, 2021-2027
Figure 119: Middle East NGS Market (High-Throughput, by Offering), $Million, 2021-2027
Figure 120: Asia-Pacific NGS Market (Medium-Throughput), $Million, 2021-2027
Figure 121: Asia-Pacific NGS Market (Medium-Throughput, by Equipment), Units, 2021-2027
Figure 122: Asia-Pacific NGS Market (Medium-Throughput, by Offering), $Million, 2021-2027
Figure 123: Middle East NGS Market (Medium-Throughput), $Million, 2021-2027
Figure 124: Middle East NGS Market (Medium-Throughput, by Equipment), Units, 2021-2027
Figure 125: Middle East NGS Market (Medium-Throughput, by Offering), $Million, 2021-2027
Figure 126: Asia-Pacific NGS Market (Low-Throughput), $Million, 2021-2027
Figure 127: Asia-Pacific NGS Market (Low-Throughput, by Equipment), Units, 2021-2027
Figure 128: Asia-Pacific NGS Market (Low-Throughput, by Offering), $Million, 2021-2027
Figure 129: Middle East NGS Market (Low-Throughput), $Million, 2021-2027
Figure 130: Middle East NGS Market (Low-Throughput, by Equipment), Units, 2021-2027
Figure 131: Middle East NGS Market (Low-Throughput, by Offering), $Million, 2021-2027
Figure 132: Asia-Pacific NGS Market (Technology Type), $Million, 2021-2027
Figure 133: Asia-Pacific NGS Market (by Technology Type), Share (%), 2021 and 2027
Figure 134: Asia-Pacific NGS Market (Sequencing by Synthesis), $Million, 2021-2027
Figure 135: Asia-Pacific NGS Market (Ion Torrent Semiconductor Sequencing), $Million, 2021-2027
Figure 136: Asia-Pacific NGS Market (Single Molecule Real-Time Sequencing), $Million, 2021-2027
Figure 137: Asia-Pacific NGS Market (Nanopore Sequencing Technology), $Million, 2021-2027
Figure 138: Asia-Pacific NGS Market (Other Technologies), $Million, 2021 and 2027
Figure 139: Asia-Pacific NGS Market (Application), $Million, 2021-2027
Figure 140: Asia-Pacific NGS Market (by Application), Share (%), 2021 and 2027
Figure 141: Use of NGS in Clinical Diagnostics
Figure 142: Asia-Pacific NGS Market (Clinical Diagnostics), $Million, 2021-2027
Figure 143: Asia-Pacific NGS Market (by Clinical Diagnostics), Share (%), 2021 and 2027
Figure 144: Applications of NGS in Oncology
Figure 145: Asia-Pacific NGS Market (Oncology), $Million, 2021-2027
Figure 146: Role of NGS in Infectious Diseases
Figure 147: Asia-Pacific NGS Market (Infectious Diseases), $Million, 2021-2027
Figure 148: Role of NGS in Reproductive Genetics
Figure 149: Asia-Pacific NGS Market (Reproductive Genetics), $Million, 2021-2027
Figure 150: Asia-Pacific NGS Market (Other Diagnostics Applications), $Million, 2021-2027
Figure 151: Asia-Pacific NGS Market (Translational Research), $Million, 2021-2027
Figure 152: Asia-Pacific NGS Market (by Translational Research), Share (%), 2021 and 2027
Figure 153: Asia-Pacific NGS Market (Clinical Research), $Million, 2021-2027
Figure 154: Asia-Pacific NGS Market (by Clinical Research), $Million, 2021-2027
Figure 155: Asia-Pacific NGS Market (by Clinical Research), Share (%), 2021 and 2027
Figure 156: Asia-Pacific NGS Market (Agricultural Research), $Million, 2021-2027
Figure 157: Asia-Pacific NGS Market (Other Translational Research), $Million, 2021-2027
Figure 158: Asia-Pacific NGS Market (Other Applications), $Million, 2021-2027
Figure 159: Asia-Pacific NGS Market (by End User), Share (%), 2021 and 2027
Figure 160: Asia-Pacific NGS Market (Academic and Research Institutes), $Million, 2021-2027
Figure 161: Asia-Pacific NGS Market (Academic and Research Institutes, by Offering), $Million, 2021-2027
Figure 162: Asia-Pacific NGS Market (Clinical Laboratories), $Million, 2021-2027
Figure 163: Asia-Pacific NGS Market (Clinical Laboratories, by Offering), $Million, 2021-2027
Figure 164: Asia-Pacific NGS Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2027
Figure 165: Asia-Pacific NGS Market (Pharmaceutical and Biotechnology Companies, by Offering), $Million, 2021-2027
Figure 166: Asia-Pacific NGS Market (Other End Users), $Million, 2021-2027
Figure 167: Asia-Pacific NGS Market (Other End Users, by Offering), $Million, 2021-2027
Figure 168: Asia-Pacific NGS Market (by Country)
Figure 169: Japan NGS Market (by Offering), $Million, 2021-2027
Figure 170: Japan NGS Market (Equipment), Units, 2021-2027
Figure 171: Japan NGS Market (by Platform), $Million, 2021-2027
Figure 172: India NGS Market (by Offering), $Million, 2021-2027
Figure 173: India NGS Market (Equipment), Units, 2021-2027
Figure 174: India NGS Market (by Platform), $Million, 2021
Figure 175: South Korea NGS Market (by Offering), $Million, 2021-2027
Figure 176: South Korea NGS Market (Equipment), Units, 2021-2027
Figure 177: South Korea NGS Market (by Platform), $Million, 2021-2027
Figure 178: Australia NGS Market (by Offering), $Million, 2021-2027
Figure 179: Australia NGS Market (Equipment), Units, 2021-2027
Figure 180: Australia NGS Market (by Platform), $Million, 2021-2027
Figure 181: Singapore NGS Market (by Offering), $Million, 2021-2027
Figure 182: Singapore NGS Market (Equipment), Units, 2021-2027
Figure 183: Singapore NGS Market (by Platform), $Million, 2021-2027
Figure 184: New Zealand NGS Market (by Offering), $Million, 2021-2027
Figure 185: New Zealand NGS Market (Equipment), Units, 2021-2027
Figure 186: New Zealand NGS Market (by Platform), $Million, 2021
Figure 187: Rest-of-Asia-Pacific NGS Market (by Offering), $Million, 2021-2027
Figure 188: Rest-of-Asia-Pacific NGS Market (Equipment), Units, 2021-2027
Figure 189: Rest-of-Asia-Pacific NGS Market (by Platform), $Million, 2021-2027
Figure 190: Middle East NGS Market (by Country)
Figure 191: U.A.E. NGS Market (by Offering), $Million, 2021-2027
Figure 192: U.A.E. NGS Market (Equipment), Units, 2021-2027
Figure 193: U.A.E NGS Market (by Platform), $Million, 2021-2027
Figure 194: K.S.A. NGS Market (by Offering), $Million, 2021-2027
Figure 195: K.S.A. NGS Market (Equipment), Units, 2021-2027
Figure 196: KSA NGS Market (by Platform), $Million, 2021-2027
Figure 197: Egypt NGS Market (by Offering), $Million, 2021-2027
Figure 198: Egypt NGS Market (Equipment), Units, 2021-2027
Figure 199: Egypt NGS Market (by Platform), $Million, 2021-2027
Figure 200: Israel NGS Market (by Offering), $Million, 2021-2027
Figure 201: Israel NGS Market (Equipment), Units, 2021-2027
Figure 202: Israel NGS Market (by Platform), $Million, 2021-2027
Figure 203: Rest-of-Middle East NGS Market (by Offering), $Million, 2021-2027
Figure 204: Rest-of-Middle East NGS Market (Equipment), Units, 2021-2027
Figure 205: Rest-of-Middle East NGS Market (by Platform), $Million, 2021-2027
Figure 206: Share of Key Developments, January 2019-January 2023
Figure 207: Share of Synergistic Activities (by Company), January 2019-January 2023
Figure 208: Share of Business Expansions and Funding Activities (by Company), January 2019-January 2023
Figure 209: Share of Product Launches/Upgradations/Approvals (by Company), January 2019-January 2023
Figure 210: Market Share Analysis for Asia-Pacific and Middle East NGS Market, 2021 and 2027
Figure 211: Growth-Share Analysis for Asia-Pacific NGS Market (by End User), 2021
Figure 212: Growth-Share Analysis for Middle East NGS Market (by Throughput), 2021
Figure 213: Share of Company Profiled
Figure 214: BGI Group: Overall Product Portfolio
Figure 215: Illumina, Inc.: Overall Product Portfolio
Figure 216: Illumina, Inc.: Overall Financials, $Million, 2019-2021
Figure 217: Illumina, Inc.: Segment Revenues, $Million, 2019-2021
Figure 218: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 219: Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 220: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 221: Thermo Fisher Scientific Inc.: Segment Revenues, $Million, 2019-2021
Figure 222: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 223: Pacific Biosciences of California, Inc.: Overall Product Portfolio
Figure 224: Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2019-2021
Figure 225: Pacific Biosciences of California, Inc.: Segment Revenue, $Million, 2019-2021
Figure 226: Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 227: Oxford Nanopore Technologies plc.: Overall Product Portfolio
Figure 228: Oxford Nanopore Technologies plc.: Overall Financials, $Million, 2019-2021
Figure 229: Oxford Nanopore Technologies plc.: Segment Revenue, $Million, 2019-2021
Figure 230: Oxford Nanopore Technologies plc.: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Asia-Pacific and Middle East NGS Market, Yearly Key Developments Analysis, January 2019-January 2023
Table 2: Key Questions Answered in the Report
Table 3: Legal Requirements and Framework in Asia-Pacific (by Country)
Table 4: Legal Requirements and Framework in the Middle East (by Country)
Table 5: Genome Projects (by Country)
Table 6: Major Sequencers in NGS Market, Performance Comparative Analysis
Table 7: Asia-Pacific and Middle East NGS Market, Maintenance Cost of NGS Equipment
Table 8: Asia-Pacific and Middle East NGS Market, Examples of Portable Sequencers
Table 9: Some Examples of Sequencing by Synthesis Technology
Table 10: Some Examples of Ion Torrent Semiconductor Sequencing Technology
Table 11: Some Examples of Single Molecule Real-Time Sequencing Technology
Table 12: Some Examples of Nanopore Sequencing Technology
Table 13: Some of the Key Distributors in Asia-Pacific (by Company)
Table 14: Some of the Key Distributors in the Middle East (by Company)

The post Asia-Pacific and Middle East NGS Market: Focus on Offering, Platform, Throughput, Technology Type, Application, End User, and Country Analysis – Analysis and Forecast, 2022-2027 first appeared on CRI Report.

The global battery manufacturing equipment market is projected to reach $88,093.50 million by 2031 from $9,439.22 million in 2021, growing at a CAGR of 27.12% during the forecast period 2022-2031. China dominated the global battery manufacturing equipment market in 2021 due to the presence of a large electric vehicle industry, leading industry players across the supply chain, and a fast-developing economy.

Market Lifecycle Stage

The battery manufacturing equipment market is in the developing phase. The rising demand for batteries from electric vehicles along with increasing consumer awareness of environmental issues is leading to the development of the battery manufacturing equipment market. Batteries are springing up as a vital component in the evolution toward a more stable future due to their involvement in electrifying mobility and balancing power networks.

Impact

Some of the factors behind the expansion of the global battery manufacturing equipment market are increased usage of batteries in automotive, consumer electronics, healthcare, energy and power, etc. With the rising demand for batteries in end-use industries expanding, the battery manufacturing equipment market is also expected to grow simultaneously. Batteries are used in vehicles, storage devices, smart consumer electronics devices, human and health performance tools, defense equipment, etc. Further, the recent focus green environment is creating demand and research scientists from across the world are striving to create new production methods or battery chemistries that can employ more widely accessible, ecologically acceptable components, but these innovations are not yet extensively used.

Impact of COVID-19

The battery manufacturing equipment market declined in 2020 due to the adverse effects of the COVID-19 pandemic on the market and related businesses. The announcement of lockdown around the globe created various issues for the battery manufacturing equipment market, including cash-flow constraints, supply chain issues, a lack of trained workers, and a slump in demand from major end-use industries. End-use industries for the battery manufacturing equipment market, such as automotive, registered declined growth due to the closure of factories and supply chain disruption from 2019-2020. According to the European Automobile Manufacturer’s Association (ACEA), total sales of new vehicles in the European Union (EU) in January and February 2020 were 7.4% lower than in the same period in 2019. Moreover, surging sales of EVs after the lockdown and growing demand from the automotive, energy and power, and consumer electronics industries are expected to help the market make a swift recovery.

Market Segmentation:

Segmentation 1: by Application

• Automotive
• Consumer Electronics
• Energy and Power
• Others (Healthcare, power tools, etc.)

Based on application, the automotive segment dominated the battery manufacturing equipment market in 2021 and was the largest segment due to the rising sales of electric vehicles across the globe. Favorable governmental regulations are the dominant driver fueling growth in the adoption of the automotive Li-ion battery. Officials from a multitude of separate nations are collaborating with automobile manufacturers to seek solutions to the escalating issues of ecological sustainability and the clean energy balance.

Segmentation 2: Equipment by Process

• Electrode Manufacturing
• Cell Assembly
• Cell Finishing

Based on equipment by process, the electrode manufacturing segment held the majority share in the battery manufacturing equipment market in the year 2021 as it is the most intricate part of the process. It is the initial step in the process, and the complete value chain of the battery is dependent on it. Further, the maximum amount of energy consumption happens at this stage.

Segmentation 3: by Battery Type

• Lithium-Ion
• Lead Acid
• Nickel Cadmium
• Nickel Metal Hydride
• Others (Sodium, Carbon Zinc, Silver Oxide, etc.)

Based on battery type, the lithium-ion segment held the majority share in the battery manufacturing equipment market in 2021. Lithium-ion batteries are a preferred source of power for low-carbon technologies such as electric vehicles. Due to their quantity of energy, they can retain in a relatively small area, charging capabilities, and propensity to remain functional after hundreds, if not thousands, of charge cycles. These batteries are an essential component of the present drive to phase out gas-powered automobiles that release carbon dioxide and other carbon pollution. Furthermore, these batteries are excellent choices for power storage for the electric grid due to their similar qualities.

Segmentation 4: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Spain, Italy, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, South Korea, India, Taiwan, and Rest-of-Asia-Pacific and Japan
• Rest-of-the-World – Middle East and Africa and South America

China dominates the battery manufacturing equipment market due to the presence of a large electric vehicle industry, leading industry players across the supply chain, and a fast-developing economy. The region holds the majority of lithium-ion reserves in the world and has the potential to utilize them in various end-use industries such as automotive, consumer electronics, and others.

Recent Developments in the Global Battery Manufacturing Equipment Market

• In May 2022, by aiding customers in the U.S. with battery manufacture, Xiamen Tmax Equipments maintained a favorable connection with them. It offered them the pouch cell pilot line, which comprises 52 machines ranging from mixing to testing. In accordance with the real requirements of the customer, Xiamen Tmax Equipments supplied complete solutions for the production of coin cells, cylinder cells, pouch cells, prismatic cells, and battery packs on a lab, pilot, and large-scale.
• In June 2022, Wuxi Lead Intelligent Equipment Co., Ltd. signed a contract with Volkswagen to deliver 20GWh lithium battery manufacturing equipment. The company would strengthen its presence in the European market and mark a new era of its global operation.

Demand – Drivers and Limitations

The following are the demand drivers for the global battery manufacturing equipment market:

• Rising Demand for Electric Vehicles (EVs)
• Government Initiatives to Reduce Carbon Footprints and e-Waste

The market is expected to face some limitations too due to the following challenge:

• Rising Cost and Competitive Pressure for Battery Equipment Manufactures
• Logistics and Supply Chain Risks

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different equipment by process, and battery type available for the battery manufacturing equipment market and its potential globally. Moreover, the study gives the reader a detailed understanding of the different equipment with usage in several applications.

Growth/Marketing Strategy: Business expansion, partnership, collaboration, and joint venture are some key strategies adopted by the key players operating in the space; for instance, in September 2022, Manz AG, GROB-WERKE, and Dürr formed a unique European alliance in the realm of lithium-ion battery production technology.

Competitive Strategy: Key players in the battery manufacturing equipment market are analyzed and profiled in the study involving battery manufacturing equipment manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the battery manufacturing equipment market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Wuxi Lead Intelligent Equipment Co., Ltd.
• SHENZHEN YINGHE TECHNOLOGY CO., LTD.
• Targray
• Xiamen Tmax Equipments
• DAIICHI JITSUGYO CO., LTD. (DJA)
• SOVEMA GROUP S.p.A.
• Battery Technology Source Co. Ltd. (BTS)
• Hitachi High-Tech Corporation
• CKD
• Manz AG
• Wirtz Manufacturing
• Buhler
• HIRANO TECSEED Co., Ltd
• Foshan Golden Milky Way Intelligent Equipment Co., Ltd. (GMK)
• Readco Kurimoto, LLC
• Lyric
• Shanghai Putailai New Energy Technology Co., Ltd.
• Super Components

The post Battery Manufacturing Equipment Market – A Global and Regional Analysis: Focus on Application, Equipment by Process, Battery Type, and Region – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

The global supersonic and hypersonic aircraft market was valued at $4,137.3 million in 2021, and it is expected to reach $5,400.4 million by 2032, growing at a CAGR of 2.73% during the forecast period 2022-2032. The manufacturers of supersonic and hypersonic aircraft are witnessing a high demand from the defense industry as well as is expected to enter the commercial market by 2025 at the earliest. The ecosystem of the supersonic and hypersonic aircraft manufacturing market comprises aircraft manufacturers, subsystem manufacturers, and end users.

Market Lifecycle Stage

High Mach propulsion, unmanned systems, and efficient turbine-based engines have reached advanced development stages in the past decade. The growth and innovations were mostly driven by the requirements of defense arms of the involved nations. However, toward the end of the last decade, several startups and emerging players have entered the highly competitive market, intending to bring both hypersonic and supersonic platforms for both commercial and military end users.

The growth in private players is attributed in part to the proliferation of key design and testing methods in the emerging market, much like the sudden abundance of players in the launch vehicle market since the introduction of SpaceX. Both government agencies and established defense manufacturers are hoping to de-risk development costs and scale innovations in this market by supporting these emerging players throughout their development stages. For instance, in July 2022, Northrop Grumman and Boom Supersonic signed a partnership agreement to develop military variants of the Overture Aircraft with special mission capabilities, which accelerated the adoption of the Boom Overture by prime market players in defense

Impact

• The increasing number of emerging players in the supersonic and hypersonic aircraft market developing platforms for passenger flights, sub-orbital cargo flights, and LEO-based services, in addition to defense applications, has placed a high demand for the production of supersonic and hypersonic aircraft during the forecast period.
• Furthermore, the increasing number of modernization programs to replace aging 4th generation fighters with newer platforms has contributed to the increasing demand for these aircraft by military end users.

Market Segmentation:

Segmentation 1: by Speed Regime

• Supersonic Aircraft
• Hypersonic Aircraft

Based on speed regime, the global supersonic and hypersonic aircraft market is expected to be dominated by the demand for supersonic aircraft during the forecast period. This is due to the long development timelines, subsystem integration challenges, and costs of development associated with the adoption of hypersonic aircraft. Since supersonic aircraft have an operational history in commercial as well as military aviation, the growth of such platforms is expected to be higher.

Segmentation 2: by Application

• Military
• Commercial

Based on application, the global supersonic and hypersonic aircraft market is expected to be dominated by demand from defense agencies during the forecast period. The adoption for the military application of supersonic and hypersonic aircraft is higher and is led by modernization programs to replace old fighters as well as the development of new hypersonic capabilities by defense forces.

Segmentation 3: by Subsystem

• Airframe
• Propulsion
• Avionics
• Control Systems
• Electrical Systems
• Commercial and Military Payload Systems
• Landing Gear

Based on subsystem, the global supersonic and hypersonic aircraft market will witness the highest demand for the airframe subsystem, followed closely by the propulsion subsystem. Both subsystems are critical for supersonic and hypersonic flight, and manufacturers are adopting methods to increase innovations in both production and performance of these major subsystems.

Segmentation 4: by Region

• North America – U.S.
• Europe – France, Germany, Russia, U.K., Turkey, and Rest-of-Europe
• Asia-Pacific – China, India, Japan, and Rest-of-Asia-Pacific

Recent Developments in Global Supersonic and Hypersonic Aircraft Market

• In August 2022, American Airlines signed a multi-billion-dollar prebook order for Boom Supersonics’ Overture Aircraft, a supersonic 70-passenger jet that is expected to enter the commercial aviation market by 2029.
• In November 2021, Hypersonix Launch Systems Limited completed the development of its DART AE hypersonic drone. DART uses a hydrogen fuel-based scramjet engine called SPARTAN that provides air-breathing thrust to the drone up to Mach 12.
• In June 2021, Reaction Engines Ltd. completed the testing for its SABRE engine. This unique engine is being developed to provide thrust from the ground and up to the speed of Mach 5.4 without any additional propulsion unit. The successful demonstration of this air-breathing engine has been followed by partnership agreements and contracts to develop a hypersonic flight-capable aircraft around the SABRE engine.

Demand – Drivers and Limitations

Following are the demand drivers for the global supersonic and hypersonic aircraft market:

• Increased Demand in Military and Commercial Air-Cargo Flights
• Modernization Programs of Manned and Unmanned Military Aircraft
• Technology Adoption: Aviation Manufacturing and Space-Tech innovations

Following are the challenges for the global supersonic and hypersonic aircraft market:

• Regulatory Laws for International and Domestic Supersonic Flights
• Increased Maintenance Costs for Critical Airframe and Engine Components
• Sustainable Operational Costs for Commercial Airline Operators
• Environmental Pollution and Aircraft Noise Concerns

Following are the opportunities for the global supersonic and hypersonic aircraft market:

• Growing Demand for Multirole Capable High-Speed Platforms
• Sustainable Zero-Carbon Propulsion Systems and Propellant Adoption

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the relevant innovations at the subsystem level that impact the uptake of products in the market. Moreover, the study provides the reader with a detailed understanding of the different propulsion systems being developed for different types of platforms that are expected to enter the future market. The product segment also outlines the considerations for the purchase and deployment of supersonic and hypersonic platforms from the operator’s point of view, encompassing both manned and unmanned aircraft. Lastly, the demand for platforms based on speed regime is provided, with developments partitioned by supersonic manned and unmanned aircraft and unmanned hypersonic aircraft.

Growth/Marketing Strategy: The global supersonic and hypersonic aircraft market has seen major development by key players operating in the market, such as business expansion activities, contracts, mergers, partnerships, collaborations, and joint ventures. The favored strategy for the companies has been contracts to strengthen their position in the supersonic and hypersonic aircraft market. For instance, in November 2020, BAE Systems was awarded a $1.25 billion order to support the production of 38 Eurofighter Typhoon aircraft for the German Air Force.

Competitive Strategy: Key players in the global supersonic and hypersonic aircraft market analyzed and profiled in the study involve aircraft manufacturers as well as subsystem manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the global supersonic and hypersonic aircraft market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as contracts, partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysis of the company’s coverage, product portfolio, and market penetration.

The top segment players leading the market include established players of supersonic and hypersonic aircraft, who constitute 60% of the presence in the market. Other players include startup entities and emerging players that account for approximately 40% of the presence in the market.

Some prominent names established in this market are:

• BAE Systems plc
• Baykar Technology
• Boom Technology, Inc.
• Dassault Aviation SA
• Destinus SA
• Exosonic, Inc.
• Hermeus Corporation
• Hypersonix Launch Systems Ltd.
• Lockheed Martin Corporation
• Northrop Grumman Corporation
• GE Group
• Raytheon Technologies Corporation
• Reaction Engines Limited
• Rolls-Royce plc.
• The Boeing Company

The post Supersonic and Hypersonic Aircraft Market – A Global and Regional Analysis: Focus on Application, Subsystem, Speed Regime, and Country – Analysis and Forecast, 2022-2032 first appeared on CRI Report.

On the other hand, certain factors restraining the growth of the market include the high cost associated with AMD. The current mainstay of treatment for AMD is anti-Vascular Endothelial Growth Factor agents (anti-VEGF) with demonstrated efficacy in improving visual acuity. There are various anti-VEGF drugs available to treat AMD, but three are most commonly used for the condition. Two of these, namely, Lucentis (ranibizumab) and Eylea (aflibercept) are specifically designed and are FDA-approved for the treatment of AMD. The third drug, Avastin (bevacizumab) was originally developed to treat cancer but is commonly used off-label in patients with AMD.
The average cost of AMD treatment with Lucentis is approximately USD 2000, and with Eylea, it is around USD 1800. However, an average AMD treatment cost with Avastin is USD 50. Although Avastin carries a similarly high price tag, as Lucentis and Eylea, when used for colon cancer, in case of eye treatment, it is less expensive because only 1/40th of the drug is being used for each dose.
The global market for age-related macular degeneration is estimated to reach USD 11,186.8 million by 2023, from USD 7,128.4 million in 2017. The market is projected to grow at a CAGR of 7.80%, during the forecast period of 2017 to 2023.
On the basis of type, the market for age-related macular degeneration is segmented into dry age-related macular degeneration and wet age-related macular degeneration. By type, the market for wet age-related macular degeneration accounted for the largest market share in 2017.
On the basis of stages, the market for age-related macular degeneration is segmented into early age-related macular degeneration, intermediate age-related macular degeneration, and late age-related macular degeneration. By stages, the market for intermediate age-related macular degeneration accounted for the largest market share in 2017.
The global age-related macular degeneration market, by age group, is segmented into above 40 years, above 60 years, and above 75 years. By age, the market for above 75 years accounted for the largest market share in 2017.
The global age-related macular degeneration, by diagnosis and treatment type, is segmented into diagnosis and treatment. The treatment segment holds the largest market share in the global age-related macular degeneration market, by diagnosis and treatment.
On the basis of route of administration, the global age-related macular degeneration market is segmented into intravenous, intravitreal, and others. The intravitreal segment dominates the global age-related macular degeneration market.
The global age-related macular degeneration market, on the basis of end-user, is segmented into hospitals and clinics, diagnostic centers, academic research institutes, and others. Hospitals and clinics hold the largest market share in the global age-related macular degeneration market.
Key Players
The key players for the age-related macular degeneration market are F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals co, and others.
Study Objectives
• To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
• To provide insights into factors influencing and affecting the market growth
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global age-related macular degeneration market

Target Audience
• Pharmaceutical and Medical Device Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Manager
• Research Companies
Key Findings
• The major market players in the global age-related macular degeneration market are F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals co, and others
• F. Hoffmann-La Roche AG accounted for more than 13.2% share of the global age-related macular degeneration market
• Based on type, the wet age-related macular degeneration segment commanded the largest market share in 2017 and was valued at USD 4,423.5 million in 2017
• Based on stages, the intermediate Age-Related Macular Degeneration (AMD) segment commanded the largest market share in 2017 and was valued at USD 3,224.6 million in 2017
• On the basis of region, the American region is projected to be the fastest growing region, at a CAGR of 7.86% during the forecast period

Regional Analysis
Americas
• North America
o US
o Canada
• South America
Europe
• Western Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Western Europe
• Eastern Europe
Asia-Pacific
o China
o Japan
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
The Middle East & Africa
• Middle East
• Africa

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing geriatric population and increasing prevalence of age-related macular degeneration
5.2.2 Several branded drugs going off patent
5.3 Restraints
5.3.1 High cost associated with AMD
5.3.2 Stringent FDA regulations
5.4 Opportunities
5.4.1 Strong pipeline
5.5 Pipeline Analysis
5.5.1 Brolucizumab 6 mg
5.5.2 NCT01691261
5.5.3 NCT03102138
5.5.4 Lampalizumab
5.5.5 RG7716
5.5.6 Emixustat
5.5.7 Zimura Dry AMD
5.5.8 Zimura Wet AMD
5.5.9 GSK933776
5.5.10 RXI-109
5.5.11 Abicipar Pegol
6 Market Factor Analysis
6.1 Supply Chain Analysis
6.1.1 R&D
6.1.2 Parts Manufacturing
6.1.3 Distribution
6.1.4 Marketing & Sales
6.1.5 Post-Sales Monitoring
6.2 Porter’s Five Forces Analysis
6.2.1 Bargaining Power of Suppliers
6.2.2 Bargaining Power of Buyers
6.2.3 Threat of New Entrants
6.2.4 Threat of Substitutes
6.2.5 Intensity of Rivalry
7 Global Age-Related Macular Degeneration Market, by Type
7.1 Overview
7.1.1 Introduction
7.1.2 Wet Age-Related Macular Degeneration (Wet AMD)
7.1.3 Dry Age-Related Macular Degeneration (Dry AMD)
8 Global Age-Related Macular Degeneration Market, by Stages
8.1 Overview
8.1.1 Introduction
8.1.2 Intermediate stage age-related macular degeneration
8.1.3 Early-stage age-related macular degeneration
8.1.4 Late stage age-related macular degeneration
9 Global Age-Related Macular Degeneration Market, by Age Group
9.1 Overview
9.1.1 Introduction
9.1.2 Above 75 years
9.1.3 Above 60 years
9.1.4 Above 40 years
10 Global Age-Related Macular Degeneration Market, by Diagnosis & Treatment
10.1 Overview
10.1.1 Introduction
10.1.2 Treatment
10.1.3 Diagnosis
11 Global Age-Related Macular Degeneration Market, by Route of Administration
11.1 Overview
11.1.1 Introduction
11.1.2 Intravitreal route of administration
11.1.3 Intravenous route of administration
12 Global Age-Related Macular Degeneration Market, By End-User
12.1 Overview
12.1.1 Introduction
12.1.2 Hospital & Clinics
12.1.3 Diagnostic Centers
12.1.4 Academic research institutes
13 Age-Related Macular Degeneration Market, by Region
13.1 Introduction
13.2 Americas
13.2.1 North America
13.2.1.1 U.S.
13.2.1.2 Canada
13.2.2 South America
13.3 Europe
13.3.1 Western Europe
13.3.1.1 Germany
13.3.1.2 France
13.3.1.3 U.K
13.3.1.4 Italy
13.3.1.5 Spain
13.3.1.6 Rest of Western Europe
13.3.2 Eastern Europe
13.4 Asia Pacific
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 Australia
13.4.5 Republic of Korea
13.4.6 Rest of Asia Pacific
13.5 The Middle East and Africa
13.5.1 Middle East
13.5.2 Africa
14 Competitive Landscape
14.1 Company Market Share Analysis
14.1.1 Introduction
14.2 Key Strategic Analysis
14.2.1 Introduction
15 Company Profiles
15.1 Novartis AG
15.1.1 Company Overview
15.1.2 Financial Overview
15.1.3 Products Offering
15.1.4 Key Developments
15.1.5 SWOT Analysis
15.1.6 Key Strategy
15.2 Pfizer Inc.
15.2.1 Company Overview
15.2.2 Financial Overview
15.2.3 Products Offering
15.2.4 Key Developments
15.2.5 SWOT Analysis
15.2.6 Key Strategy
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Overview
15.3.2 Financial Overview
15.3.3 Products Offering
15.3.4 Key Developments
15.3.5 SWOT Analysis
15.3.6 Key Strategy
15.4 Acucela Inc.
15.4.1 Company Overview:
15.4.2 Financial Overview
15.4.3 Products Offering
15.4.4 Key Developments
15.4.5 SWOT Analysis
15.4.6 Key Strategy
15.5 Ophthotech Corporation
15.5.1 Company Overview
15.5.2 Financial Overview
15.5.3 Products Offering
15.5.4 Key Developments
15.5.5 SWOT Analysis
15.5.6 Key Strategy
15.6 GlaxoSmithKline Plc.
15.6.1 Company Overview
15.6.2 Financial Overview
15.6.3 Products Offering
15.6.4 Key Developments
15.6.5 SWOT Analysis
15.6.6 Key Strategy
15.7 Bayer AG
15.7.1 Company Overview
15.7.2 Financial Overview
15.7.3 Products Offering
15.7.4 Key Developments
15.7.5 SWOT Analysis
15.7.6 Key Strategy
15.8 Rxi Pharmaceuticals, Inc.
15.8.1 Company Overview
15.8.2 Financial Overview
15.8.3 Pipeline Products
15.8.4 Key Developments
15.8.5 SWOT Analysis
15.8.6 Key Strategy
15.9 Regeneron Pharmaceutical Inc.
15.9.1 Company Overview
15.9.2 Financial Overview
15.9.3 Products Offering
15.9.4 Key Developments
15.9.5 SWOT Analysis
15.9.6 Key Strategy
15.1 Alimera Sciences Inc.
15.10.1 Company Overview
15.10.2 Financial Overview
15.10.3 Pipeline Products
15.10.4 Key Developments
15.10.5 SWOT Analysis
15.10.6 Key Strategy
15.11 Santen Pharmaceuticals co.
15.11.1 Company Overview
15.11.2 Financial Overview
15.11.3 Products Offering
15.11.4 SWOT Analysis
15.11.5 Key Developments
15.11.6 Key Strategy
15.12 ALLERGAN
15.12.1 Company Overview
15.12.2 Financial Overview
15.12.3 Products Offering
15.12.4 SWOT Analysis
15.12.5 Key Developments
15.12.6 Key Strategy
15.13 Bausch & Lomb Incorporated
15.13.1 Company Overview
15.13.2 Financial Overview
15.13.3 Products Offering
15.13.4 Key Developments
15.13.5 SWOT Analysis
15.13.6 Key Strategy
16 Appendix
16.1 Discussion Blue Print

The post Global Age-related macular degeneration Market – Global Forecast Till 2023 first appeared on CRI Report.